Luminor Medical Technologies Inc. (LMT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,357,000 | 2,261,000 | 2,656,000 | 2,722,000 | 3,288,000 |
| Marketable Securities | 504,000 | 516,000 | 767,000 | 877,000 | N/A |
| Receivables | 6,583,000 | 5,757,000 | 6,275,000 | 6,383,000 | 6,610,000 |
| Inventories | 2,277,000 | 2,378,000 | 2,093,000 | 2,360,000 | 2,476,000 |
| Income taxes - deferred | 1,156,000 | 1,038,000 | 930,000 | 962,000 | 839,000 |
| Other current assets | 866,000 | 901,000 | 1,218,000 | 908,000 | 706,000 |
| TOTAL | $14,743,000 | $12,851,000 | $13,939,000 | $14,212,000 | $13,919,000 |
| Non-Current Assets | |||||
| PPE Net | 4,461,000 | 4,554,000 | 4,347,000 | 4,381,000 | 4,436,000 |
| Intangibles | 9,609,000 | 9,605,000 | 9,746,000 | 9,976,000 | 10,221,000 |
| Other Non-Current Assets | 7,864,000 | 8,057,000 | 7,519,000 | 7,670,000 | 7,711,000 |
| TOTAL | $21,934,000 | $22,216,000 | $21,612,000 | $22,027,000 | $22,368,000 |
| Total Assets | $36,677,000 | $35,067,000 | $35,551,000 | $36,239,000 | $36,287,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,374,000 | 1,627,000 | 2,352,000 | 2,271,000 | 2,247,000 |
| Other current liabilities | 2,404,000 | 1,941,000 | 2,336,000 | 2,710,000 | 2,406,000 |
| TOTAL | $12,430,000 | $11,157,000 | $11,638,000 | $11,859,000 | $11,572,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,023,000 | 5,019,000 | 5,019,000 | 5,019,000 | 5,053,000 |
| Deferred Revenues | 5,844,000 | 5,719,000 | 5,060,000 | 5,180,000 | 5,274,000 |
| Other Non-Current Liabilities | 15,433,000 | 15,183,000 | 14,976,000 | 15,627,000 | 15,634,000 |
| TOTAL | $20,456,000 | $20,202,000 | $19,995,000 | $20,646,000 | $20,687,000 |
| Total Liabilities | $32,886,000 | $31,359,000 | $31,633,000 | $32,505,000 | $32,259,000 |
| Shareholders' Equity | |||||
| Common Shares | 345,000 | 346,000 | 358,000 | 360,000 | 369,000 |
| Retained earnings | 12,274,000 | 12,372,000 | 12,150,000 | 11,988,000 | 12,267,000 |
| Other shareholders' equity | -8,828,000 | -9,010,000 | -8,590,000 | -8,614,000 | -8,608,000 |
| TOTAL | $3,791,000 | $3,708,000 | $3,918,000 | $3,734,000 | $4,028,000 |
| Total Liabilities And Equity | $36,677,000 | $35,067,000 | $35,551,000 | $36,239,000 | $36,287,000 |